INTRODUCTION: The present study was designed to assess whether [(18)F]PK-209 (3-(2-chloro-5-(methylthio)phenyl)-1-(3-([(18)F]fluoromethoxy)phenyl)-1-methylguanidine) is a suitable ligand for imaging the ion-channel site of N-methyl-D-aspartate receptors (NMDArs) using positron emission tomography (PET). METHODS: Dynamic PET scans were acquired from male rhesus monkeys over 120min, at baseline and after the acute administration of dizocilpine (MK-801, 0.3mg/kg; n=3/condition). Continuous and discrete arterial blood samples were manually obtained, to generate metabolite-corrected input functions. Parametric volume-of-distribution (VT) images were obtained using Logan analysis. The selectivity profile of PK-209 was assessed in vitro, on a broad screen of 79 targets. RESULTS: PK-209 was at least 50-fold more selective for NMDArs over all other targets examined. At baseline, prolonged retention of radioactivity was observed in NMDAr-rich cortical regions relative to the cerebellum. Pretreatment with MK-801 reduced the VT of [(18)F]PK-209 compared with baseline in two of three subjects. The rate of radioligand metabolism was high, both at baseline and after MK-801 administration. CONCLUSIONS: PK-209 targets the intrachannel site with high selectivity. Imaging of the NMDAr is feasible with [(18)F]PK-209, despite its fast metabolism. Further in vivo evaluation in humans is warranted.
INTRODUCTION: The present study was designed to assess whether [(18)F]PK-209 (3-(2-chloro-5-(methylthio)phenyl)-1-(3-([(18)F]fluoromethoxy)phenyl)-1-methylguanidine) is a suitable ligand for imaging the ion-channel site of N-methyl-D-aspartate receptors (NMDArs) using positron emission tomography (PET). METHODS: Dynamic PET scans were acquired from male rhesus monkeys over 120min, at baseline and after the acute administration of dizocilpine (MK-801, 0.3mg/kg; n=3/condition). Continuous and discrete arterial blood samples were manually obtained, to generate metabolite-corrected input functions. Parametric volume-of-distribution (VT) images were obtained using Logan analysis. The selectivity profile of PK-209 was assessed in vitro, on a broad screen of 79 targets. RESULTS: PK-209 was at least 50-fold more selective for NMDArs over all other targets examined. At baseline, prolonged retention of radioactivity was observed in NMDAr-rich cortical regions relative to the cerebellum. Pretreatment with MK-801 reduced the VT of [(18)F]PK-209 compared with baseline in two of three subjects. The rate of radioligand metabolism was high, both at baseline and after MK-801 administration. CONCLUSIONS: PK-209 targets the intrachannel site with high selectivity. Imaging of the NMDAr is feasible with [(18)F]PK-209, despite its fast metabolism. Further in vivo evaluation in humans is warranted.
Authors: Marc S Lener; Mark J Niciu; Elizabeth D Ballard; Minkyung Park; Lawrence T Park; Allison C Nugent; Carlos A Zarate Journal: Biol Psychiatry Date: 2016-05-12 Impact factor: 13.382
Authors: Ali K Vibholm; Anne M Landau; Arne Møller; Jan Jacobsen; Kim Vang; Ole L Munk; Dariusz Orlowski; Jens Ch Sørensen; David J Brooks Journal: J Cereb Blood Flow Metab Date: 2020-09-22 Impact factor: 6.200
Authors: Jasper van der Aart; Maqsood Yaqub; Esther J M Kooijman; Jaco Bakker; Jan A M Langermans; Robert C Schuit; Mark B M Hofman; Johannes A M Christiaans; Adriaan A Lammertsma; Albert D Windhorst; Bart N M van Berckel Journal: Mol Imaging Biol Date: 2019-08 Impact factor: 3.488
Authors: Gregory R Naumiec; Kimberley J Jenko; Sami S Zoghbi; Robert B Innis; Lisheng Cai; Victor W Pike Journal: J Med Chem Date: 2015-12-04 Impact factor: 7.446
Authors: Jasper van der Aart; Sandeep S V Golla; Marieke van der Pluijm; Lothar A Schwarte; Robert C Schuit; Pieter J Klein; Athanasios Metaxas; Albert D Windhorst; Ronald Boellaard; Adriaan A Lammertsma; Bart N M van Berckel Journal: EJNMMI Res Date: 2018-07-27 Impact factor: 3.138
Authors: Athanasios Metaxas; Bart N M van Berckel; Pieter J Klein; Joost Verbeek; Emily C Nash; Esther J M Kooijman; Véronique A Renjaän; Sandeep S V Golla; Ronald Boellaard; Johannes A M Christiaans; Albert D Windhorst; Josée E Leysen Journal: Pharmacol Res Perspect Date: 2019-02
Authors: Francisco R López-Picón; Thomas Keller; Diana Bocancea; Jatta S Helin; Anna Krzyczmonik; Semi Helin; Annelaure Damont; Frédéric Dollé; Juha O Rinne; Merja Haaparanta-Solin; Olof Solin Journal: Mol Imaging Biol Date: 2021-09-20 Impact factor: 3.488